Aruna Subramanian

5.0/5

2 Patient Ratings

37 Patient Reviews

Aruna Subramanian

Infectious diseases doctor

Clinical Professor, Medicine - Infectious Diseases

View Professional Summary

Additional Languages Spoken:

Spanish , Tamil

Insurance Coverage

Resources for Referring Physicians

Biography

Clinical Focus: Chief, Immunocompromised Host Infectious Diseases

This includes the prevention, diagnosis and treatment of Infections in patients who are immunosuppressed because of:

Solid Organ Transplantation (Kidney, Pancreas, Liver, Heart, Lung, Small Bowel)
Bone Marrow (Hematopoeitic Cell) Transplants
Hematologic Malignancies
Chemotherapy for Solid Tumors
HIV who receive Chemotherapy,Solid Organ or Bone Marrow Transplants
Immunomodulators for Auto-Immune Diseases

View Full Biography

Professional Summary

Education & Certifications

Board Certification: American Board of Internal Medicine, Infectious Disease (2024)
Board Certification: American Board of Internal Medicine, Internal Medicine (2024)
Fellowship: Johns Hopkins University Division of Infectious Diseases (2000) MD
- Medical Education: University of Michigan Medical School (1994) MI
- Residency: University Hospitals of Cleveland - Case Western Reserve (1997) OH
- Fellowship, Johns Hopkins University School of Medicine, Infectious Diseases (2001)
- Residency, University Hospitals of Cleveland (Case Western Reserve), Internal Medicine (1997)
- Medical School, University of Michigan, Medicine (1994)

View More Education & Certifications

Honors & Awards

Associate Editor, Transplant Infectious Diseases Journal (2004-2016)
Award for Outstanding Research, Case Western Reserve University (UHC) (1997)
Fellow of AST (FAST), American Society of Transplantation (2018)
- Fellow of IDSA (FIDSA), Infectious Diseases Society of America (2014)
- Sidney Finegold Outstanding Reviewer Award, Clinical Infectious Diseases Journal (2009)
- William Dodd Robinson Award for Excellence in Internal Medicine, University of Michigan (1994)

View More Honors & Awards

Administrative Appointments

Chief, Immunocompromised Host ID Service, Stanford University, Division of Infectious Diseases (2013 - Present)
Co-Director, Transplant and Oncology ID Service, Johns Hopkins University School of Medicine (2003 - 2011)
Co-PI, AIDS Clinical Trials Unit, Johns Hopkins University School of Medicine (2001 - 2003)

Publications

Mycobacterium tuberculosis Infections in Solid Organ Transplantation
Subramanian, A. K., & Morris, M. I. (2013). Mycobacterium tuberculosis Infections in Solid Organ Transplantation. AMERICAN JOURNAL OF TRANSPLANTATION, 13, 68–76.
Epidemiology, risk factors, and outcomes of Clostridium difficile infection in kidney transplant recipients
Neofytos, D., Kobayashi, K., Alonso, C. D., Cady-Reh, J., Lepley, D., Harris, M., … Marr, K. (2013). Epidemiology, risk factors, and outcomes of Clostridium difficile infection in kidney transplant recipients. TRANSPLANT INFECTIOUS DISEASE, 15(2), 134–141.
Outcomes of Kidney Transplantation in HIV-Infected Recipients
Stock, P. G., Barin, B., Murphy, B., Hanto, D., Diego, J. M., Light, J., … Roland, M. E. (2010). Outcomes of Kidney Transplantation in HIV-Infected Recipients. NEW ENGLAND JOURNAL OF MEDICINE, 363(21), 2004–14.
- Recommended curriculum for subspecialty training in transplant infectious disease on behalf of the American Society of Transplantation Infectious Diseases Community of Practice Educational Initiatives Working Group
  Avery, R., CLAUSS, H., Danziger-Isakov, L., Davis, J., Doucette, K., van Duin, D., … Subramanian, A. (2010). Recommended curriculum for subspecialty training in transplant infectious disease on behalf of the American Society of Transplantation Infectious Diseases Community of Practice Educational Initiatives Working Group. TRANSPLANT INFECTIOUS DISEASE, 12(3), 190–194.
- MELD Score Is an Important Predictor of Pretransplantation Mortality in HIV-Infected Liver Transplant Candidates
  Subramanian, A., Sulkowski, M., Barin, B., Stablein, D., Curry, M., Nissen, N., … Ragni, M. (2010). MELD Score Is an Important Predictor of Pretransplantation Mortality in HIV-Infected Liver Transplant Candidates. GASTROENTEROLOGY, 138(1), 159–64.
- Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection
  Terrault, N. A., Roland, M. E., Schiano, T., Dove, L., Wong, M. T., Poordad, F., … Stock, P. G. (2012). Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. LIVER TRANSPLANTATION, 18(6), 716–726.
- Donor-derived organ transplant transmission of coccidioidomycosis
  Dierberg, K. L., Marr, K. A., Subramanian, A., Nace, H., Desai, N., Locke, J. E., … Neofytos, D. (2012). Donor-derived organ transplant transmission of coccidioidomycosis. TRANSPLANT INFECTIOUS DISEASE, 14(3), 300–304.
- Fungal infection presenting as giant cell tubulointerstitial nephritis in kidney allograft
  Bagnasco, S. M., Subramanian, A. K., & Desai, N. M. (2012). Fungal infection presenting as giant cell tubulointerstitial nephritis in kidney allograft. TRANSPLANT INFECTIOUS DISEASE, 14(3), 288–291.
- Tuberculosis in solid organ transplant candidates and recipients: current and future challenges.
  Subramanian, A. K. (2014). Tuberculosis in solid organ transplant candidates and recipients: current and future challenges. Current Opinion in Infectious Diseases, 27(4), 316–21.
- False-positive QuantiFERON TB-Gold test due to Mycobacterium gordonae
  Gajurel, K., & Subramanian, A. K. (2016). False-positive QuantiFERON TB-Gold test due to Mycobacterium gordonae. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 84(4), 315–17.
- False-positive hepatitis C virus serology after placement of a ventricular assistance device
  Durand, C. M., Marr, K. A., OSTRANDER, D., Subramanian, A., Valsamakis, A., Cox, A., & Neofytos, D. (2016). False-positive hepatitis C virus serology after placement of a ventricular assistance device. TRANSPLANT INFECTIOUS DISEASE, 18(1), 146–49.
- Cutaneous zygomycosis (mucormycosis)
  Carpenter, C. F., & Subramanian, A. K. (1999). Cutaneous zygomycosis (mucormycosis). NEW ENGLAND JOURNAL OF MEDICINE, 341(25), 1891–91.
- Renal Transplant in HIV-Positive Patients Long-term Outcomes and Risk Factors for Graft Loss
  Locke, J. E., Montgomery, R. A., Warren, D. S., Subramanian, A., & Segev, D. L. (2009). Renal Transplant in HIV-Positive Patients Long-term Outcomes and Risk Factors for Graft Loss. ARCHIVES OF SURGERY, 144(1), 83–86.
- Provider Response to a Rare but Highly Publicized Transmission of HIV Through Solid Organ Transplantation
  Kucirka, L. M., Ros, L., Subramanian, A. K., Montgomery, R. A., & Segev, D. L. (2011). Provider Response to a Rare but Highly Publicized Transmission of HIV Through Solid Organ Transplantation. ARCHIVES OF SURGERY, 146(1), 41–45.
- The high-risk donor: viral infections in solid organ transplantation
  Singer, A. L., Kucirka, L. M., Namuyinga, R., Hanrahan, C., Subramanian, A. K., & Segev, D. L. (2008). The high-risk donor: viral infections in solid organ transplantation. CURRENT OPINION IN ORGAN TRANSPLANTATION, 13(4), 400–404.
- Correlation of Chlamydia pneumoniae infection and severity of accelerated graft arteriosclerosis after cardiac transplantation
  Subramanian, A. K., Quinn, T. C., Kickler, T. S., Kasper, E. K., & Tucker, P. C. (2002). Correlation of Chlamydia pneumoniae infection and severity of accelerated graft arteriosclerosis after cardiac transplantation. TRANSPLANTATION, 73(5), 761–64.
- Incidence and risk factors for hepatocellular carcinoma after solid organ transplantation
  Hoffmann, C. J., Subramanian, A. K., Cameron, A. M., & Engels, E. A. (2008). Incidence and risk factors for hepatocellular carcinoma after solid organ transplantation. TRANSPLANTATION, 86(6), 784–90.
- Nontuberculous Mycobacteria in Solid Organ Transplant Recipients
  Dorman, S., & Subramanian, A. (2009). Nontuberculous Mycobacteria in Solid Organ Transplant Recipients. AMERICAN JOURNAL OF TRANSPLANTATION, 9, S63–S69.
- Antimicrobial prophylaxis regimens following transplantation
  Subramanian, A. K. (2011). Antimicrobial prophylaxis regimens following transplantation. CURRENT OPINION IN INFECTIOUS DISEASES, 24(4), 344–49.
- Mycobacterium tuberculosis in Solid Organ Transplant Recipients
  Subramanian, A., & Dorman, S. (2009). Mycobacterium tuberculosis in Solid Organ Transplant Recipients. AMERICAN JOURNAL OF TRANSPLANTATION, 9, S57–S62.
- Actinomucor elegans as an Emerging Cause of Mucormycosis
  Mahmud, A., Lee, R., Munfus-McCray, D., Kwiatkowski, N., Subramanian, A., Neofytos, D., … Zhang, S. X. (2012). Actinomucor elegans as an Emerging Cause of Mucormycosis. JOURNAL OF CLINICAL MICROBIOLOGY, 50(3), 1092–95.
- Images in clinical medicine. Cutaneous zygomycosis (Mucormycosis).
  Carpenter, C. F., & Subramanian, A. K. (1999). Images in clinical medicine. Cutaneous zygomycosis (Mucormycosis). New England Journal of Medicine, 341(25), 1891-?
- West Nile virus encephalitis in a kidney transplant recipient
  Shepherd, J. C., Subramanian, A., Montgomery, R. A., Samaniego, M. D., Gong, G., Bergmann, A., … Dropulic, L. (2004). West Nile virus encephalitis in a kidney transplant recipient. AMERICAN JOURNAL OF TRANSPLANTATION, 4(5), 830–33.
- Should a prisoner be placed on the organ transplant waiting list?
  Cameron, A. M., Subramanian, A. K., Sulkowski, M. S., Thomas, D. L., & Nelson, K. E. (2008). Should a prisoner be placed on the organ transplant waiting list? The Virtual Mentor : VM, 10(2), 88–91.
- Detection and treatment of Strongyloides hyperinfection syndrome following lung transplantation
  Balagopal, A., Mills, L., Shah, A., & Subramanian, A. (2009). Detection and treatment of Strongyloides hyperinfection syndrome following lung transplantation. TRANSPLANT INFECTIOUS DISEASE, 11(2), 149–54.
- Use of Alternative Agents for Prevention of Opportunistic Infections in Heart and Lung Transplant Recipients.
  Epstein, D. J., Benamu, E., & Subramanian, A. (2018). Use of Alternative Agents for Prevention of Opportunistic Infections in Heart and Lung Transplant Recipients. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America.
- Tolerability of Fluoroquinolones in Management of Latent Tuberculosis in Liver Transplant Candidates
  Tien, V., Robilotti, E., Callister, D., Subramanian, A., Lutchman, G., & Ho, D. Y. (2015). Tolerability of Fluoroquinolones in Management of Latent Tuberculosis in Liver Transplant Candidates. CLINICAL INFECTIOUS DISEASES, 61(10), 1631–U154.
- Tuberculosis Recommendations for Solid Organ Transplant Recipients and Donors
  Santoro-Lopes, G., Subramanian, A. K., Molina, I., Maria Aguado, J., Rabagliatti, R., & Len, O. (2018). Tuberculosis Recommendations for Solid Organ Transplant Recipients and Donors. TRANSPLANTATION, 102(2), S60–S65.
- Prevention and Management of Tuberculosis in Solid Organ Transplant Recipients.
  Epstein, D. J., & Subramanian, A. K. (2018). Prevention and Management of Tuberculosis in Solid Organ Transplant Recipients. Infectious Disease Clinics of North America, 32(3), 703–18.
- Native Kidney Cytomegalovirus Nephritis and Cytomegalovirus Prostatitis in a Kidney Transplant Recipient.
  Tan, S. K., Cheng, X. S., Kao, C.-S., Weber, J., Pinsky, B. A., Gill, H. S., … Tan, J. C. (2018). Native Kidney Cytomegalovirus Nephritis and Cytomegalovirus Prostatitis in a Kidney Transplant Recipient. Transplant Infectious Disease : an Official Journal of the Transplantation Society, e12998.
- Infections in Transplant and Oncology Patients Preface
  Marr, K. A., & Subramanian, A. K. (2010). Infections in Transplant and Oncology Patients Preface. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 24(2), XIII-XV.
- Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls.
  Roland, M. E., Barin, B., Huprikar, S., Murphy, B., Hanto, D. W., Blumberg, E., … Stock, P. G. (2016). Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls. AIDS (London, England), 30(3), 435–44.
- Liver Transplantation for HCV Non-Viremic Recipients with HCV Viremic Donors.
  Kwong, A. J., Wall, A., Melcher, M., Wang, U., Ahmed, A., Subramanian, A., & Kwo, P. Y. (2018). Liver Transplantation for HCV Non-Viremic Recipients with HCV Viremic Donors. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
- Mycobacterium tuberculosis Infections in Solid Organ Transplantation: Guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation.
  Subramanian, A. K., & Theodoropoulos, N. M. (2019). Mycobacterium tuberculosis Infections in Solid Organ Transplantation: Guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation. Clinical Transplantation, e13513.
- Impact of Pre-Transplant Donor BK Viruria in Kidney Transplant Recipients.
  Tan, S. K., Huang, C. H., Sahoo, M. K., Weber, J., Kurzer, J., Stedman, M. R., … Pinsky, B. A. (2019). Impact of Pre-Transplant Donor BK Viruria in Kidney Transplant Recipients. The Journal of Infectious Diseases.
- Association of Antibiotic Resistance With Antibiotic Use for Epidermal Growth Factor Receptor Inhibitor-Related Papulopustular Eruption.
  Hirotsu, K., Dang, T. M., Li, S., Neal, J. W., Pugliese, S., Subramanian, A., & Kwong, B. Y. (2019). Association of Antibiotic Resistance With Antibiotic Use for Epidermal Growth Factor Receptor Inhibitor-Related Papulopustular Eruption. JAMA Dermatology.
- Use of Alternative Agents for Prevention of Opportunistic Infections in Heart and Lung Transplant Recipients
  Epstein, D. J., Benamu, E., & Subramanian, A. K. (2018). Use of Alternative Agents for Prevention of Opportunistic Infections in Heart and Lung Transplant Recipients. CLINICAL INFECTIOUS DISEASES, 67(10), 1637–39.
- Successful eradication of chronic symptomatic Candida krusei urinary tract infection with increased dose micafungin in a liver and kidney transplant recipient: case report and review of the literature.
  Multani, A., Subramanian, A. K., & Liu, A. Y. (2019). Successful eradication of chronic symptomatic Candida krusei urinary tract infection with increased dose micafungin in a liver and kidney transplant recipient: case report and review of the literature. Transplant Infectious Disease : an Official Journal of the Transplantation Society, e13118.
- Liver transplantation for hepatitis C virus (HCV) non-viremic recipients with HCV viremic donors
  Kwong, A. J., Wall, A., Melcher, M., Wang, U., Ahmed, A., Subramanian, A., & Kwo, P. Y. (2019). Liver transplantation for hepatitis C virus (HCV) non-viremic recipients with HCV viremic donors. AMERICAN JOURNAL OF TRANSPLANTATION, 19(5), 1380–87.
- Incidence of Active Tuberculosis Following Hematopoietic Cell Transplantation: A Small but Real Threat.
  Aronson, J. R., Rezvani, A. R., & Subramanian, A. (2019). Incidence of Active Tuberculosis Following Hematopoietic Cell Transplantation: A Small but Real Threat. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America.
- Impact of Pretransplant Donor BK Viruria in Kidney Transplant Recipients
  Tan, S. K., Huang, C. H., Sahoo, M. K., Weber, J., Kurzer, J., Stedman, M. R., … Pinsky, B. A. (2019). Impact of Pretransplant Donor BK Viruria in Kidney Transplant Recipients. JOURNAL OF INFECTIOUS DISEASES, 220(3), 370–76.
- Association of Antibiotic Resistance With Antibiotic Use for Epidermal Growth Factor Receptor Inhibitor-Related Papulopustular Eruption
  Hirotsu, K., Dang, T. M., Li, S., Neal, J. W., Pugliese, S., Subramanian, A., & Kwong, B. Y. (2019). Association of Antibiotic Resistance With Antibiotic Use for Epidermal Growth Factor Receptor Inhibitor-Related Papulopustular Eruption. JAMA DERMATOLOGY, 155(7), 848–50.
- Mycobacterium tuberculosis infections in solid organ transplantation: Guidelines from the infectious diseases community of practice of the American Society of Transplantation
  Subramanian, A. K., & Theodoropoulos, N. M. (2019). Mycobacterium tuberculosis infections in solid organ transplantation: Guidelines from the infectious diseases community of practice of the American Society of Transplantation. CLINICAL TRANSPLANTATION, 33(9).
- A Multicenter, Longitudinal Cohort Study of Cryptococcosis in Human Immunodeficiency Virus-negative People in the United States
  Marr, K. A., Sun, Y., Spec, A., Lu, N., Panackal, A., Bennett, J., … Powderly, W. (2020). A Multicenter, Longitudinal Cohort Study of Cryptococcosis in Human Immunodeficiency Virus-negative People in the United States. CLINICAL INFECTIOUS DISEASES, 70(2), 252–61.
- Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection.
  Webb, B. J., Subramanian, A., Lopansri, B., Goodman, B., Jones, P. B., Ferraro, J., … Brown, S. M. (2020). Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection. Antimicrobial Agents and Chemotherapy.
- Characteristics and outcomes of coronavirus disease patients under nonsurge conditions, northern California, USA, March–April 2020
  Ferguson, J., Rosser, J., Quintero, O., Scott, J., Subramanian, A., Gumma, M., … Kappagoda, S. (2020). Characteristics and outcomes of coronavirus disease patients under nonsurge conditions, northern California, USA, March–April 2020. Emerging Infectious Diseases.
- Infections Related to Biologics.
  Ho, D. Y., & Subramanian, A. K. (2020). Infections Related to Biologics. Infectious Disease Clinics of North America, 34(2), xiii-xvi.
- Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.
  Goldman, J. D., Lye, D. C., Hui, D. S., Marks, K. M., Bruno, R., Montejano, R., … Subramanian, A. (2020). Remdesivir for 5 or 10 Days in Patients with Severe Covid-19. The New England Journal of Medicine.
- A single-cell atlas of the peripheral immune response in patients with severe COVID-19.
  Wilk, A. J., Rustagi, A., Zhao, N. Q., Roque, J., Martinez-Colon, G. J., McKechnie, J. L., … Blish, C. A. (2020). A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Nature Medicine.
- Simultaneous Coccidioidomycosis and Phaeohyphomycosis in a Kidney Transplant Recipient: A Case Report and Literature Review.
  Puing, A. G., Couture-Cossette, A., Wang, A. X., Zygourakis, C. C., Cheng, X., Stevens, B. A., … Subramanian, A. (2020). Simultaneous Coccidioidomycosis and Phaeohyphomycosis in a Kidney Transplant Recipient: A Case Report and Literature Review. Transplant Infectious Disease : an Official Journal of the Transplantation Society, e13365.
- Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis.
  Wilson, J. G., Simpson, L. J., Ferreira, A.-M., Rustagi, A., Roque, J. A., Asuni, A., … Rogers, A. J. (2020). Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis. JCI Insight.
- Use of Remdesivir for Pregnant Patients with Severe Novel 2019 Coronavirus Disease.
  Igbinosa, I., Miller, S., Bianco, K., Nelson, J., Kappagoda, S., Blackburn, B. G., … Aziz, N. (2020). Use of Remdesivir for Pregnant Patients with Severe Novel 2019 Coronavirus Disease. American Journal of Obstetrics and Gynecology.
- Quantifying Infection Risks in Incompatible Living Donor Kidney Transplant Recipients.
  Avery, R. K., Motter, J. D., Jackson, K. R., Montgomery, R. A., Massie, A. B., Kraus, E. S., … Garonzik, J. M. (2020). Quantifying Infection Risks in Incompatible Living Donor Kidney Transplant Recipients. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
- IMPACT OF BASELINE ALANINE AMINOTRANSFERASE LEVELS ON THE SAFETY AND EFFICACY OF REMDESIVIR IN SEVERE COVID-19 PATIENTS
  Goldman, J. D., Lye, D. C. B., Hui, D. S.-C., Marks, K., Bruno, R., Montejano, R., … Subramanian, A. (2020). IMPACT OF BASELINE ALANINE AMINOTRANSFERASE LEVELS ON THE SAFETY AND EFFICACY OF REMDESIVIR IN SEVERE COVID-19 PATIENTS. HEPATOLOGY, 72, 279A.
- A single-cell atlas of the peripheral immune response to severe COVID-19.
  Wilk, A. J., Rustagi, A., Zhao, N. Q., Roque, J., Martinez-Colon, G. J., McKechnie, J. L., … Blish, C. A. (2020). A single-cell atlas of the peripheral immune response to severe COVID-19. MedRxiv : the Preprint Server for Health Sciences.
- Clinical Accuracy and Impact of Plasma Cell-Free DNA Fungal PCR Panel for Non-Invasive Diagnosis of Fungal Infection.
  Senchyna, F., Hogan, C. A., Murugesan, K., Moreno, A., Ho, D. Y., Subramanian, A., … Banaei, N. (2021). Clinical Accuracy and Impact of Plasma Cell-Free DNA Fungal PCR Panel for Non-Invasive Diagnosis of Fungal Infection. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America.
- Patients with uncomplicated COVID-19 have long-term persistent symptoms and functional impairment similar to patients with severe COVID-19: a cautionary tale during a global pandemic.
  Jacobson, K. B., Rao, M., Bonilla, H., Subramanian, A., Hack, I., Madrigal, M., … Grant, P. (2021). Patients with uncomplicated COVID-19 have long-term persistent symptoms and functional impairment similar to patients with severe COVID-19: a cautionary tale during a global pandemic. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America.
- SARS-CoV-2 subgenomic RNA kinetics in longitudinal clinical samples
  Verma, R., Kim, E., Martinez, G., Jagannathan, P., Rustagi, A., Parsonnet, J., … Andrews, J. (2021). SARS-CoV-2 subgenomic RNA kinetics in longitudinal clinical samples. Open Forum Infectious Diseases.
- An aberrant inflammatory response in severe COVID-19.
  Merad, M., Subramanian, A., & Wang, T. T. (2021). An aberrant inflammatory response in severe COVID-19. Cell Host & Microbe, 29(7), 1043–1047.
- SARS-CoV-2 Neutralization Resistance Mutations in Patient with HIV/AIDS, California, USA.
  Hoffman, S. A., Costales, C., Sahoo, M. K., Palanisamy, S., Yamamoto, F., Huang, C. H., … Pinsky, B. A. (2021). SARS-CoV-2 Neutralization Resistance Mutations in Patient with HIV/AIDS, California, USA. Emerging Infectious Diseases, 27(10).
- Nocardiosis in Immunocompromised Patients on Alternative Pneumocystis Prophylaxis.
  Puing, A. G., Epstein, D. J., Banaei, N., Subramanian, A. K., & Liu, A. Y. (2021). Nocardiosis in Immunocompromised Patients on Alternative Pneumocystis Prophylaxis. Emerging Infectious Diseases, 27(10), 2734–2736.
- Active surveillance of serious adverse events following transfusion of COVID-19 convalescent plasma.
  Swenson, E., Wong, L. K., Jhaveri, P., Weng, Y., Kappagoda, S., Pandey, S., … Hollenhorst, M. (2021). Active surveillance of serious adverse events following transfusion of COVID-19 convalescent plasma. Transfusion.
- Survivors of SARS-CoV-2 Infection Show Neuropsychiatric Sequelae Measured by Surveys, Neurocognitive Testing, and Magnetic Resonance Imaging: Preliminary Results
  Hack, L., Brawer, J., Zhang, X., Wintermark, M., Jiang, B., Stetz, P., … Williams, L. (2021). Survivors of SARS-CoV-2 Infection Show Neuropsychiatric Sequelae Measured by Surveys, Neurocognitive Testing, and Magnetic Resonance Imaging: Preliminary Results. NEUROPSYCHOPHARMACOLOGY. SPRINGERNATURE.
- Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity.
  Chakraborty, S., Gonzalez, J. C., Sievers, B. L., Mallajosyula, V., Chakraborty, S., Dubey, M., … Wang, T. T. (1800). Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity. Science Translational Medicine, eabm7853.
- Epidemiology of invasive fungal diseases in adults with newly diagnosed acute myeloid leukemia.
  Miranti, E., Ho, D. Y., Enriquez, K., Subramanian, A. K., Medeiros, B. C., & Epstein, D. J. (2022). Epidemiology of invasive fungal diseases in adults with newly diagnosed acute myeloid leukemia. Leukemia & Lymphoma, 1–7.
- Favipiravir for treatment of outpatients with asymptomatic or uncomplicated COVID-19: a double-blind randomized, placebo-controlled, phase 2 trial.
  Holubar, M., Subramanian, A., Purington, N., Hedlin, H., Bunning, B., Walter, K. S., … Maldonado, Y. (2022). Favipiravir for treatment of outpatients with asymptomatic or uncomplicated COVID-19: a double-blind randomized, placebo-controlled, phase 2 trial. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America.
- COVID-19 in the Immunocompromised Host, Including People with Human Immunodeficiency Virus.
  Jakharia, N., Subramanian, A. K., & Shapiro, A. E. (2022). COVID-19 in the Immunocompromised Host, Including People with Human Immunodeficiency Virus. Infectious Disease Clinics of North America, 36(2), 397–421.
- Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study.
  Hu, Z., van der Ploeg, K., Chakraborty, S., Arunachalam, P. S., Mori, D. A., Jacobson, K. B., … Jagannathan, P. (2022). Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study. ELife, 11.
- Infective endocarditis in solid organ transplant: a review.
  Suarez, J. F., & Subramanian, A. K. (2022). Infective endocarditis in solid organ transplant: a review. Current Opinion in Organ Transplantation, 27(4), 263–268.
- Challenges in Harnessing Shared Within-Host Severe Acute Respiratory Syndrome Coronavirus 2 Variation for Transmission Inference.
  Walter, K. S., Kim, E., Verma, R., Altamirano, J., Leary, S., Carrington, Y. J., … Andrews, J. R. (2023). Challenges in Harnessing Shared Within-Host Severe Acute Respiratory Syndrome Coronavirus 2 Variation for Transmission Inference. Open Forum Infectious Diseases, 10(2), ofad001.
- Myalgic Encephalomyelitis/Chronic Fatigue Syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): Results from a post-COVID-19 multidisciplinary clinic.
  Bonilla, H., Quach, T. C., Tiwari, A., Bonilla, A. E., Miglis, M., Yang, P. C., … Geng, L. C. (2023). Myalgic Encephalomyelitis/Chronic Fatigue Syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): Results from a post-COVID-19 multidisciplinary clinic. Frontiers in Neurology, 14, 1090747.
- Mycobacteria in Organ Transplant Recipients.
  Narsana, N., Alejandra Perez, M., & Subramanian, A. (2023). Mycobacteria in Organ Transplant Recipients. Infectious Disease Clinics of North America.
- Use of a severe acute respiratory coronavirus virus 2 (SARS-CoV-2) strand-specific assay to evaluate for prolonged viral replication >20 days from illness onset.
  Ferguson, J. D., Tayyar, R., Contreras, G., Kiener, M., Zimmet, A. N., Contag, C. A., … Salinas, J. L. (2023). Use of a severe acute respiratory coronavirus virus 2 (SARS-CoV-2) strand-specific assay to evaluate for prolonged viral replication >20 days from illness onset. Infection Control and Hospital Epidemiology, 1–3.
- Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patients.
  Teh, B. W., Mikulska, M., Averbuch, D., de la Camara, R., Hirsch, H. H., Akova, M., … Slavin, M. A. (2023). Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patients. The Lancet. Infectious Diseases.
- Low infectivity among asymptomatic patients with a positive severe acute respiratory coronavirus virus 2 (SARS-CoV-2) admission test at a tertiary care center, 2020-2022.
  Tayyar, R., Kiener, M. A., Liang, J. W., Contreras, G., Rodriguez-Nava, G., Zimmet, A. N., … Salinas, J. L. (2023). Low infectivity among asymptomatic patients with a positive severe acute respiratory coronavirus virus 2 (SARS-CoV-2) admission test at a tertiary care center, 2020-2022. Infection Control and Hospital Epidemiology, 1–3.
- Nirmatrelvir-Ritonavir and Symptoms in Adults With Postacute Sequelae of SARS-CoV-2 Infection: The STOP-PASC Randomized Clinical Trial.
  Geng, L. N., Bonilla, H., Hedlin, H., Jacobson, K. B., Tian, L., Jagannathan, P., … Singh, U. (2024). Nirmatrelvir-Ritonavir and Symptoms in Adults With Postacute Sequelae of SARS-CoV-2 Infection: The STOP-PASC Randomized Clinical Trial. JAMA Internal Medicine.
- Sex differences and immune correlates of Long COVID development, persistence, and resolution.
  Hamlin, R. E., Pienkos, S. M., Chan, L., Stabile, M. A., Pinedo, K., Rao, M., … Blish, C. A. (2024). Sex differences and immune correlates of Long COVID development, persistence, and resolution. BioRxiv : the Preprint Server for Biology.
- Effectiveness of heterologous and homologous COVID-19 vaccination among immunocompromised individuals: a systematic literature review and meta-analysis.
  Pardo, I., Maezato, A. M., Callado, G. Y., Gutfreund, M. C., Hsieh, M. K., Lin, V., … Marra, A. R. (2024). Effectiveness of heterologous and homologous COVID-19 vaccination among immunocompromised individuals: a systematic literature review and meta-analysis. Antimicrobial Stewardship & Healthcare Epidemiology : ASHE, 4(1), e152.
- Infections in decompensated cirrhosis: Pathophysiology, management, and research agenda.
  Ferguson Toll, J., Solà, E., Perez, M. A., Piano, S., Cheng, A., Subramanian, A. K., & Kim, W. R. (2024). Infections in decompensated cirrhosis: Pathophysiology, management, and research agenda. Hepatology Communications, 8(10).
- Sex differences and immune correlates of Long Covid development, symptom persistence, and resolution.
  Hamlin, R. E., Pienkos, S. M., Chan, L., Stabile, M. A., Pinedo, K., Rao, M., … Blish, C. A. (2024). Sex differences and immune correlates of Long Covid development, symptom persistence, and resolution. Science Translational Medicine, 16(773), eadr1032.

View More Publications

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Open Trials Closed Trials

Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT

Practice Locations

Infectious Diseases Clinic in Palo Alto Palo Alto, CA

Palo Alto, CA

Infectious Diseases Clinic in Palo Alto

211 Quarry Rd, 2nd Fl Ste 202

Palo Alto , CA 94304

(650) 736-5200

More Clinic Information

Heart Transplant Program Stanford, CA

Stanford, CA

Heart Transplant Program

300 Pasteur Dr, 2nd Fl Rm A21

Stanford , CA 94305

(650) 723-5468

More Clinic Information

(301) Post-Acute COVID-19 Syndrome (PACS) Clinic Atherton, CA

Atherton, CA

(301) Post-Acute COVID-19 Syndrome (PACS) Clinic

3351 El Camino Real, Ste 225

Atherton , CA 94027

(650) 736-5200

More Clinic Information

Important Information about Our Organizations and Physician Affiliation

Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.

Patient Ratings

(2 Ratings)

Overall Rating

5.0/5

View Ratings by Category

5.0/5

Friendliness

5.0/5

Explanations

5.0/5

Listens

5.0/5

Care provider's efforts to include you in decisions about your care

5.0/5

Recommended to others

0.0/5

Wait times

How Our Ratings Work

The Patients Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.

Patient Satisfaction Survey Disclaimer

Patient Reviews

(37 reviews)

I liked her bed side bedside manners, very knowledgeable and attentive. Pleasing personality and thorough.

Oct 2024

•

Verified SHC Patient

Dr Subramanian is a wonderful doctor, very intelligent, very nice and very thorough!

May 2024

•

Verified SHC Patient

The doctor is excellent; listens and engages.

Dec 2023

•

Verified SHC Patient

I like Dr, Subramanian and her fellows. They are very good in listening to their patients and help them.

Dec 2023

•

Verified SHC Patient

Outstanding doctor, caring and knowledgeable.

Nov 2023

•

Verified SHC Patient

She is an excellent doctor, very informative, and caring.

Sep 2023

•

Verified SHC Patient

Sheâ€™s amazing. Listens well, very intelligent, compassionate.

Aug 2023

•

Verified SHC Patient

She was professional, knowledgeable, thorough, and extremely kind! Listened to my concerns and answered all my questions. Would highly recommend

Jul 2023

•

Verified SHC Patient

I always enjoyed my visits with Dr. Subramanian because she is very informative and clearly explains the health issues and the treatment involved. She has a very pleasant personality and treats me with respect.

Jun 2023

•

Verified SHC Patient

I was very pleased with the visit. Dr. Subramanian is very kind and understanding. She asked me all the pertinent questions and explained my condition well. I felt encouraged by her comments.

Mar 2023

•

Verified SHC Patient

checked my swollen legs and feet for cellulitis or not with care

Aug 2022

•

Verified SHC Patient

I really appreciate her concern and involvement in my care. Dr. Subramanian asks questions, listens, and is responsive.

Jun 2022

•

Verified SHC Patient

I appreciate the attention and help that Drs. Subramanian and Dieringer have given me to help navigate my treatment through the health issues I have faced in the last year.

May 2022

•

Verified SHC Patient

Great doctor ðŸ‘ ðŸ‘

Apr 2022

•

Verified SHC Patient

Dr Subramanian is fantastic!! Stanford should be so glad that they have her!!

Apr 2022

•

Verified SHC Patient

Dr. Subramanian is an exceptional doctor; she has expertise, compassion, and is an extremely great listener. She is an absolute joy to talk with.

Jan 2022

•

Verified SHC Patient

Dr. Subramanian came across as knowledgeable, clear, concerned, caring and willing to help me move forward solving my medical conundrum. I very much appreciated her help.

Nov 2021

•

Verified SHC Patient

Dr Aruna Subramanian has been an excellent care provider for a difficult condition. She is a great listener and comes across as very compassionate. I am sorry to see her leave the clinic and wish her the best in future endeavors.

Nov 2021

•

Verified SHC Patient

I find Dr. Subramanian to be a compassionate doctor who goes the extra mile to help her patients. She is polite and humble and a good listener. We need more like her at Stanford!

Oct 2021

•

Verified SHC Patient

She is amazing. She is easy to talk to and offers great advice.

Oct 2021

•

Verified SHC Patient

Dr. Subramanian is a superb doctor - she is learned and articulate, compassionate, caring and careful not to meet with Chronic Fatigue patients, currently, so as not to spread Covid virus. She remembers what I have mentioned, months ago and is attentive, articulate and kind!

Sep 2021

•

Verified SHC Patient

Sheâ€™s excellent

Sep 2021

•

Verified SHC Patient

Great and caring physician

Jul 2021

•

Verified SHC Patient

She is wonderful!

Jun 2021

•

Verified SHC Patient

I cannot say enough good things about Dr. Subramanian. She was familiar with my case when she took the call, which I really appreciate. We didn't stumble around and waste precious minutes while she caught up with who I am and what we've talked about before. She honestly says when she's not as familiar with a particular treatment that I bring up. I really like that. She doesn't say, its not good or maybe its good, just is up front about how familiar with it. Also, she complied when I asked that she note one issue/treatment that she is not familiar with. I know that is she comes across information about it, she will notice and include it in our next meeting or message me sooner. As I said, I cannot say enough good things about Dr. Subramanian. I can't think of any way to improve her except to be able to see her more often. I may be forgetting something, since serious cognitive issues are part of my illness, but nothing that would decrease my high recommendation of her.

Jun 2021

•

Verified SHC Patient

Dr. Subramanian is fantastic.

Jun 2021

•

Verified SHC Patient

Helpful, caring, thorough, thoughtful, with a wonderful and quick smile!

May 2021

•

Verified SHC Patient

Dr Subramanian is amazing!

May 2021

•

Verified SHC Patient

very personable and seemed and ask a lot questions to ensure she was getting the entire story. She was also familiar with my condition prior, so she obviously did her homework :).

Apr 2021

•

Verified SHC Patient

Dr. Subramanian showed care and extreme concern for wound and possible infection.

May 2020

•

Verified SHC Patient

Dr. Subramanian was very helpful. Looked at my records before she came in and addressed all concerns. Very professional and gave me confidence.

Apr 2017

•

Verified SHC Patient

The doctor was exceptional in all phases.

Aug 2016

•

Verified SHC Patient

Dr. Subramarian always impresses me with her kind & caring manner. She always spends all the time I need answering all my questions in detail (I'm detail oriented) & asks if I agree with her recommendation. Great doctor!

May 2016

•

Verified SHC Patient

Top of the line people.

Feb 2016

•

Verified SHC Patient

Very good.

Dec 2015

•

Verified SHC Patient

Dr. Subramanian is so caring, so knowledgeable and makes me always feel better. A very sweet & kind doctor and person.

Feb 2015

•

Verified SHC Patient

First provider after several that is doing something to resolve my issue!

Aug 2014

•

Verified SHC Patient

View More Patient Reviews

Referring Physicians

PHYSICIAN HELPLINE

Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.

Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.

You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.

Send referrals online
Place radiology and lab orders
View referral status
Access medical records

Learn More About MedLink

LOG INTO MEDLINK

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

Aruna Subramanian

Infectious diseases doctor

Get In Touch

Biography

Professional Summary

Education & Certifications

Honors & Awards

Administrative Appointments

Publications

Clinical Trials

Practice Locations

Infectious Diseases Clinic in Palo Alto Palo Alto, CA

Infectious Diseases Clinic in Palo Alto

Heart Transplant Program Stanford, CA

Heart Transplant Program

(301) Post-Acute COVID-19 Syndrome (PACS) Clinic Atherton, CA

(301) Post-Acute COVID-19 Syndrome (PACS) Clinic

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Patient Reviews

(37 reviews)

Referring Physicians

PHYSICIAN HELPLINE

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

WELCOME BACK

Aruna Subramanian

Infectious diseases doctor

Get In Touch

Biography

Professional Summary

Education & Certifications

Honors & Awards

Administrative Appointments

Publications

Clinical Trials

Practice Locations

Infectious Diseases Clinic in Palo Alto Palo Alto, CA

Infectious Diseases Clinic in Palo Alto

Heart Transplant Program Stanford, CA

Heart Transplant Program

(301) Post-Acute COVID-19 Syndrome (PACS) Clinic Atherton, CA

(301) Post-Acute COVID-19 Syndrome (PACS) Clinic

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Patient Reviews

(37 reviews)

Referring Physicians

PHYSICIAN HELPLINE